Chang‐Chun Ling

771 total citations
24 papers, 530 citations indexed

About

Chang‐Chun Ling is a scholar working on Molecular Biology, Biomedical Engineering and Cancer Research. According to data from OpenAlex, Chang‐Chun Ling has authored 24 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Biomedical Engineering and 5 papers in Cancer Research. Recurrent topics in Chang‐Chun Ling's work include Nanoplatforms for cancer theranostics (8 papers), Histone Deacetylase Inhibitors Research (4 papers) and Synthesis and bioactivity of alkaloids (2 papers). Chang‐Chun Ling is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Histone Deacetylase Inhibitors Research (4 papers) and Synthesis and bioactivity of alkaloids (2 papers). Chang‐Chun Ling collaborates with scholars based in China, Hong Kong and United States. Chang‐Chun Ling's co-authors include Yong Ling, Chi Meng, Jianqiang Qian, Weijie Gao, Kwan Man, Xiangjun Fan, Changxian Li, TP Ng, Mingyan Zhu and Yibing Guo and has published in prestigious journals such as Journal of Hepatology, Magnetic Resonance in Medicine and Analytica Chimica Acta.

In The Last Decade

Chang‐Chun Ling

23 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang‐Chun Ling China 12 235 131 108 96 90 24 530
Yanfang Wang China 17 174 0.7× 61 0.5× 91 0.8× 50 0.5× 56 0.6× 31 577
Rongjian Su China 16 410 1.7× 29 0.2× 59 0.5× 101 1.1× 101 1.1× 27 654
Bentham Science Publisher SiddikUzzaman India 11 281 1.2× 27 0.2× 47 0.4× 65 0.7× 43 0.5× 18 467
Fang Sui China 14 394 1.7× 38 0.3× 85 0.8× 142 1.5× 63 0.7× 33 663
Pinjiang Cao Canada 11 327 1.4× 30 0.2× 74 0.7× 87 0.9× 60 0.7× 16 518
Can Huang China 13 323 1.4× 40 0.3× 97 0.9× 109 1.1× 117 1.3× 23 559
Pindong Li China 15 340 1.4× 38 0.3× 56 0.5× 169 1.8× 68 0.8× 29 614
Huaixin Xing China 12 437 1.9× 55 0.4× 51 0.5× 326 3.4× 80 0.9× 20 656
Daiju Ichikawa Japan 14 196 0.8× 42 0.3× 69 0.6× 47 0.5× 30 0.3× 35 494
Junping Ao China 15 434 1.8× 20 0.2× 73 0.7× 194 2.0× 86 1.0× 24 687

Countries citing papers authored by Chang‐Chun Ling

Since Specialization
Citations

This map shows the geographic impact of Chang‐Chun Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Chun Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Chun Ling more than expected).

Fields of papers citing papers by Chang‐Chun Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Chun Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Chun Ling. The network helps show where Chang‐Chun Ling may publish in the future.

Co-authorship network of co-authors of Chang‐Chun Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Chun Ling. A scholar is included among the top collaborators of Chang‐Chun Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Chun Ling. Chang‐Chun Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Tiantian, Sijia Wang, Xiao Liu, et al.. (2025). Novel ꞵ-carboline/cyanoisoflavone photosensitizers for ferroptosis-induced efficient chemo-photodynamic synergistic cancer therapy. Journal of Photochemistry and Photobiology B Biology. 265. 113135–113135. 1 indexed citations
2.
Gui, Lijuan, Weiqing Li, Yanping Pan, et al.. (2023). γ-Glutamyl transpeptidase activatable probe for fluorescence-assisted guiding surgery and imaging of human tumors via spraying. Sensors and Actuators B Chemical. 398. 134718–134718. 5 indexed citations
3.
Xu, Zhongyuan, Jianqiang Qian, Huimin Zhao, et al.. (2023). Dual Tumor-Selective β-Carboline-Based Fluorescent Probe for High-Contrast/Rapid Diagnosis of Clinical Tumor Tissues. Molecular Pharmaceutics. 21(1). 152–163. 4 indexed citations
4.
Xu, Zhongyuan, Jianqiang Qian, Hongmei Wu, et al.. (2023). Novel pH-activatable NIR fluorogenic spray mediated near-instant and precise tumor margins identification in human cancer tissues for surgical resection. Theranostics. 13(13). 4497–4511. 5 indexed citations
5.
Xu, Zhongyuan, Chi Meng, Xudong Xie, et al.. (2023). Acidic tumor microenvironment-activatable fluorescent diagnostic probe for the rapid identification and resection of human tumors via spraying. Biosensors and Bioelectronics. 234. 115343–115343. 18 indexed citations
6.
Ling, Chang‐Chun, Tiantian Sun, Fang Chen, et al.. (2023). Precise tumor delineation in clinical tissues using a novel acidic tumor microenvironment activatable near-infrared fluorescent contrast agent. Analytica Chimica Acta. 1279. 341815–341815. 6 indexed citations
7.
Ma, Yu‐Shui, Ting‐Miao Wu, Chang‐Chun Ling, et al.. (2021). M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B. Molecular Therapy — Oncolytics. 20. 484–498. 85 indexed citations
8.
Ma, Yu‐Shui, Ting‐Miao Wu, Bin Qian, et al.. (2021). KDM5A silencing transcriptionally suppresses the FXYD3‐PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR‐433 up‐regulation. Journal of Cellular and Molecular Medicine. 25(8). 4040–4052. 23 indexed citations
9.
Meng, Chi, Hongmei Wu, Haoran Wang, et al.. (2021). Novel Hybrid CHC from β-carboline and N-Hydroxyacrylamide Overcomes Drug-Resistant Hepatocellular Carcinoma by Promoting Apoptosis, DNA Damage, and Cell Cycle Arrest. Frontiers in Pharmacology. 11. 626065–626065. 11 indexed citations
10.
Ling, Yong, Jianqiang Qian, Chi Meng, et al.. (2020). Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy. Current Medicinal Chemistry. 27(42). 7264–7288. 34 indexed citations
11.
Liu, Ji‐Bin, Chang‐Chun Ling, Ting‐Miao Wu, et al.. (2020). Prognosis for intrahepatic cholangiocarcinoma patients treated with postoperative adjuvant transcatheter hepatic artery chemoembolization. Current Problems in Cancer. 44(6). 100612–100612. 8 indexed citations
12.
Meng, Chi, Jianqiang Qian, Zhongyuan Xu, et al.. (2020). Efficacy of novel methylenecyclohexenone derivatives as TrxR inhibitors in suppressing the proliferation and metastasis of human cancer cells. Bioorganic Chemistry. 105. 104360–104360. 8 indexed citations
13.
Ling, Yong, Yangyang Li, Rui Zhu, et al.. (2019). Hydroxamic Acid Derivatives of β-Carboline/Hydroxycinnamic Acid Hybrids Inducing Apoptosis and Autophagy through the PI3K/Akt/mTOR Pathways. Journal of Natural Products. 82(6). 1442–1450. 36 indexed citations
14.
Ling, Yong, Weijie Gao, Chang‐Chun Ling, et al.. (2019). β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma. European Journal of Medicinal Chemistry. 168. 515–526. 39 indexed citations
15.
Li, Changxian, Bin Yu, Lei Shi, et al.. (2016). ‘Obligate’ anaerobic Salmonella strain YB1 suppresses liver tumor growth and metastasis in nude mice. Oncology Letters. 13(1). 177–183. 26 indexed citations
16.
Zhou, Pengcheng, Yan Huang, Yibing Guo, et al.. (2015). Decellularization and Recellularization of Rat Livers With Hepatocytes and Endothelial Progenitor Cells. Artificial Organs. 40(3). E25–38. 63 indexed citations
17.
Wu, Di, Jian Wan, Yan Huang, et al.. (2015). 3D Culture of MIN-6 Cells on Decellularized Pancreatic Scaffold: In Vitro and In Vivo Study. BioMed Research International. 2015. 1–8. 40 indexed citations
18.
Ling, Chang‐Chun, TP Ng, Yan Shao, et al.. (2013). Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growth. Journal of Hepatology. 60(1). 103–109. 79 indexed citations
19.
Ling, Chang‐Chun. (2006). 62 Imaging tumor hypoxia. Radiotherapy and Oncology. 78. S22–S22.
20.
Zhang, Ping, Judith A. Appleton, Chang‐Chun Ling, & David R. Bundle. (2002). Synthesis of disaccharide congeners of the Trichinella spiralis glycan and binding site mapping of two monoclonal antibodies. Canadian Journal of Chemistry. 80(8). 1141–1161. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanfang Wang Breakdown of academic impact, for papers by Rongjian Su Breakdown of academic impact, for papers by Bentham Science Publisher SiddikUzzaman Breakdown of academic impact, for papers by Fang Sui Breakdown of academic impact, for papers by Pinjiang Cao Breakdown of academic impact, for papers by Can Huang Breakdown of academic impact, for papers by Pindong Li Breakdown of academic impact, for papers by Huaixin Xing Breakdown of academic impact, for papers by Daiju Ichikawa Breakdown of academic impact, for papers by Junping Ao
Rankless by CCL
2026